Karen E. Inouye

Karen E. Inouye

Auto-generated profile, based on publicly available information

Karen E. Inouye

Sabri Ülker Center for Metabolic Research and Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2019 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
ATAmir Tirosh
Amir Tirosh
ECEdiz S. Calay
Ediz S. Calay
GTGurol Tuncman
Gurol Tuncman
KCKathryn C. Claiborn
Kathryn C. Claiborn
KIKaren E. Inouye
Karen E. Inouye
GHGökhan S. Hotamisligil
Gökhan S. Hotamisligil
The short-chain fatty acid propionate is a potent inhibitor of molds that is widely used as a food preservative and endogenously produced by gut microbiota. Although generally recognized as safe by the U.S. Food and Drug Administration, the metabolic effects of propionate consumption in humans are unclear. Here, we report that propionate stimulates glycogenolysis and hyperglycemia in mice by increasing plasma concentrations of glucagon and fatty acid–binding protein 4 (FABP4). Fabp4-deficient mice and mice lacking liver glucagon receptor were protected from the effects of propionate. Although propionate did not directly promote glucagon or FABP4 secretion in ex vivo rodent pancreatic islets and adipose tissue models, respectively, it activated the sympathetic nervous system in mice, leading to secretion of these hormones in vivo. This effect could be blocked by the pharmacological inhibition of norepinephrine, which prevented propionate-induced hyperglycemia in mice. In a randomized, double-blind, placebo-controlled study in humans, consumption of a propionate-containing mixed meal resulted in a postprandial increase in plasma glucagon, FABP4, and norepinephrine, leading to insulin resistance and compensatory hyperinsulinemia. Chronic exposure of mice to a propionate dose equivalent to that used for food preservation resulted in gradual weight gain. In humans, plasma propionate decreased with weight loss in the Dietary Intervention Randomized Controlled Trial (DIRECT) and served as an independent predictor of improved insulin sensitivity. Thus, propionate may activate a catecholamine-mediated increase in insulin counter-regulatory signals, leading to insulin resistance and hyperinsulinemia, which, over time, may promote adiposity and metabolic abnormalities. Further evaluation of the metabolic consequences of propionate consumption is warranted.

28 May 2025 in Nature
Verified
Journal Article
Closed access
PDF file
RGRenata L. S. Goncalves
Renata L. S. Goncalves
ZWZeqiu Branden Wang
Zeqiu Branden Wang
JRJillian K. Riveros
Jillian K. Riveros
GPGüneş Parlakgül
Güneş Parlakgül
KIKaren E. Inouye
Karen E. Inouye
GHGökhan S. Hotamışlıgil
Gökhan S. Hotamışlıgil

24 July 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
KIKaren E. Inouye
Karen E. Inouye
KPKacey J. Prentice
Kacey J. Prentice
ALAlexandra Lee
Alexandra Lee
ZWZeqiu Branden Wang
Zeqiu Branden Wang
CDCarla Dominguez-Gonzalez
Carla Dominguez-Gonzalez
GHGökhan S. Hotamışlıgil
Gökhan S. Hotamışlıgil
Fatty acid binding protein 4 (FABP4) is a lipid chaperone secreted from adipocytes upon stimulation of lipolysis. Circulating FABP4 levels strongly correlate with obesity and metabolic pathologies in experimental models and humans. While adipocytes have been presumed to be the major source of hormonal FABP4, this question has not been addressed definitively in vivo. We generated mice with Fabp4 deletion in cells known to express the gene — adipocytes (Adipo-KO), endothelial cells (Endo-KO), myeloid cells (Myeloid-KO), and the whole body (Total-KO) — to examine the contribution of these cell types to basal and stimulated plasma FABP4 levels. Unexpectedly, baseline plasma FABP4 was not significantly reduced in Adipo-KO mice, whereas Endo-KO mice showed ~87% reduction versus WT controls. In contrast, Adipo-KO mice exhibited ~62% decreased induction of FABP4 responses to lipolysis, while Endo-KO mice showed only mildly decreased induction, indicating that adipocytes are the main source of increases in FABP4 during lipolysis. We did not detect any myeloid contribution to circulating FABP4. Surprisingly, despite the nearly intact induction of FABP4, Endo-KO mice showed blunted lipolysis-induced insulin secretion, identical to Total-KO mice. We conclude that the endothelium is the major source of baseline hormonal FABP4 and is required for the insulin response to lipolysis.

14 December 2021 in Science Signaling
Verified
Journal Article
Closed access
EGEkin Guney
Ekin Guney
AAAna Paula Arruda
Ana Paula Arruda
GPGünes Parlakgul
Günes Parlakgul
ECErika Cagampan
Erika Cagampan
NMNina Min
Nina Min
GHGökhan S. Hotamisligil
Gökhan S. Hotamisligil
Inhibiting IP 3 Rs in adipocytes may prevent the development of obesity-induced metabolic complications.

29 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
EGEkin Guney
Ekin Guney
AAAna Paula Arruda
Ana Paula Arruda
GPGunes Parlakgul
Gunes Parlakgul
ECErika Cagampan
Erika Cagampan
NMNina Min
Nina Min
GHGökhan S. Hotamisligil
Gökhan S. Hotamisligil
Summary: Chronic metabolic inflammation is a key feature of obesity, insulin resistance and diabetes, although the initiation and propagation mechanisms of metaflammation are not fully established, particularly in the adipose tissue. Here we show that in adipocytes, altered regulation of the Ca 2+ channel inositol triphosphate receptor (IP3Rs) is a key, adipocyte-intrinsic, event involved in the emergence and propagation of inflammatory signaling and the resulting insulin resistance. Inflammation, either induced by cytokine exposure in vitro or by obesity in vivo lead to increased expression and activity of IP3Rs in adipocytes in a JNK-dependent manner. This results in increased cytosolic Ca 2+ and impaired insulin action. In mice, adipocyte-specific loss of IP3R1/2 protected against adipose tissue inflammation and insulin resistance despite significant diet-induced weight gain. Thus, this work reveals that IP3R over-activation and the resulting increase in cytosolic Ca 2+ is a key link between obesity, inflammation and insulin resistance, and suggests that approaches to target adipocyte Ca 2+ homeostasis may offer new therapeutic opportunities against metabolic diseases, especially since GWAS studies also implicate this locus in human obesity.

10 September 2026 in JCI Insight
Verified
Journal Article
Open access
PDF file
SLSamuel C. Lapp
Samuel C. Lapp
KKKrystle C. Kalafut
Krystle C. Kalafut
MCMadi Y. Cissé
Madi Y. Cissé
KTKhaled Tighanimine
Khaled Tighanimine
DRDean M. Rosenthal
Dean M. Rosenthal
BMBrendan D. Manning
Brendan D. Manning
Activation of the mechanistic target of rapamycin (mTOR) complex1 (mTORC1) promotes muscle protein synthesis, mass, and function. Muscle mTORC1 can be activated by feeding and contraction. Here, muscle mTORC1 signaling, protein synthesis, mass, and function are characterized in a genetic mouse model that separates these 2 major modes of muscle mTORC1 regulation. AKT signaling is required for feeding-induced muscle mTORC1 signaling and protein synthesis, and mice expressing a mutant of tuberous sclerosis complex 2 (TSC2) that cannot be phosphorylated by AKT specifically in skeletal muscle (SkM-TSC2-5A) attenuate these effects of feeding. Despite this loss of postprandial protein synthesis, SkM-TSC2-5A mice have similar muscle and myofiber size compared with SkM-TSC2-WT mice. SkM-TSC2-5A mice maintain normal muscle mTORC1 activation in response to contraction and exhibit no differences in atrophy-related gene expression or ribosomal content. SkM-TSC2-5A mice exhibit improved maximal endurance capacity without changes in muscle contractile function. This phenotype occurs without alterations in muscle glycogen content or myofiber type, but it does coincide with a modest increase in muscle mitochondrial content. Therefore, AKT-mediated phosphorylation of TSC2 is required for postprandial mTORC1 activation and the induction of protein synthesis; however, these are dispensable for the development and maintenance of muscle mass in sedentary mice.